Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.

Abstract

Parkinson's disease (PD) is a chronic neurodegenerative disease, and there is no cure for it at present. Recent research has indicated a link between type 2 diabetes mellitus (T2DM) and PD, which suggested that a treatment to improve insulin resistance for T2DM may be useful for PD patients. Glucose-dependent insulinotropic polypeptide (GIP) belongs to the incretin hormone family, which can promote insulin release and improve insulin resistance. Several GIP analogues have been developed as potential treatments for T2DM. In the present study, a novel long-lasting GIP analogue, D-Ala2-GIP-glu-PAL, has been tested in an acute PD mouse model induced by four 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intraperitoneal injections. D-Ala2-GIP-glu-PAL treatment (25 nmol/kg ip.) for 7 days after MPTP treatment improved the locomotor and exploratory activity of mice, and improved bradykinesia and movement balance of mice. D-Ala2-GIP-glu-PAL treatment also restored tyrosine hydroxylase (TH) positive dopaminergic neuron numbers in the substantia nigra and TH levels in the striatum. D-Ala2-GIP-glu-PAL also reduced the chronic inflammation response as seen in astrocyte and microglia activation in the substantia nigra pars compacta (SNpc). D-Ala2-GIP-glu-PAL reversed the reduction of synapse numbers (synaptophysin levels), decreased the ratio of growth factor and apoptosis signaling molecules Bax/Bcl-2, and improved the decrease of p-CREB(S133) growth factor signaling in the substantia nigra. Therefore, D-Ala2-GIP-glu-PAL promotes cell survival of dopaminergic neuron in the SNpc by activating the cAMP/PKA/CREB growth factor second messenger pathway that also inhibits apoptosis. The present results demonstrate that D-Ala2-GIP-glu-PAL shows promise as a novel treatment of PD.

• Authors: Yanwei Li, WeiZhen Liu, Lin Li, Christian Hölscher
• Journal: Neuropharmacology (Neuropharmacology) Vol. 101 Pg. 255-63 (Feb 2016) ISSN: 1873-7064 [Electronic] England
• PMID: 26453962 (Publication Type: Journal Article)
• Copyright: Copyright © 2015 Elsevier Ltd. All rights reserved.

Chemical References

• Aif1 protein, mouse
• Calcium-Binding Proteins
• Glial Fibrillary Acidic Protein
• Microfilament Proteins
• Neuroprotective Agents
• Gastric Inhibitory Polypeptide
• Tyrosine 3-Monooxygenase

Topics

• Analysis of Variance
• Animals
• Calcium-Binding Proteins (metabolism)
• Disease Models, Animal
• Exploratory Behavior (drug effects)
• Gastric Inhibitory Polypeptide (pharmacology, therapeutic use)
• Glial Fibrillary Acidic Protein (metabolism)
• MPTP Poisoning (chemically induced, drug therapy)
• Male
• Mice
• Mice, Inbred C57BL
• Microfilament Proteins (metabolism)
• Neuroprotective Agents (pharmacology, therapeutic use)
• Postural Balance (drug effects)
• Tyrosine 3-Monooxygenase (metabolism)